A Changing Regulatory Landscape For Weight Loss Drugs

By Roger Cohen, Dustin Schaefer and Anne Brendel · May 23, 2024, 6:42 PM EDT

Prescriptions for a new class of drugs to treat obesity surged exponentially in 2023. Originally approved for treatment of Type 2 diabetes, glucagon-like peptide-1 receptor agonist drugs, or GLP-1s, such as...

To view the full article, register now.